3 Year Absolute Returns
96.26% ↑
NAV (₹) on 18 Jun 2026
380.19
1 Day NAV Change
1.00%
Risk Level
Very High Risk
Rating
-
SBI Healthcare Opportunities Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by SBI Funds Management Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP ... Read more
AUM
₹ 4,565.95 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 64.93% |
| Hospitals & Medical Services | 25.88% |
| Chemicals - Speciality | 2.65% |
| Treps/Reverse Repo | 2.48% |
| Foreign Securities | 2.14% |
| Medical Equipment & Accessories | 1.89% |
| Treasury Bill | 0.06% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.03% | ₹ 503.78 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 6.57% | ₹ 300.01 | Pharmaceuticals |
| Acutaas Chemicals Ltd. | 6.17% | ₹ 281.93 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 5.37% | ₹ 245.29 | Hospitals & Medical Services |
| Max Healthcare Institute Ltd. | 4.76% | ₹ 217.15 | Hospitals & Medical Services |
| Aurobindo Pharma Ltd. | 3.90% | ₹ 178.30 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 3.83% | ₹ 174.80 | Hospitals & Medical Services |
| Laurus Labs Ltd. | 3.58% | ₹ 163.44 | Pharmaceuticals |
| Biocon Ltd. | 3.52% | ₹ 160.74 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 3.48% | ₹ 158.79 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 3.05% | ₹ 139.27 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 3.00% | ₹ 136.96 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.96% | ₹ 135 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.91% | ₹ 133.03 | Pharmaceuticals |
| Aether Industries Ltd. | 2.65% | ₹ 120.78 | Chemicals - Speciality |
| Jupiter Life Line Hospitals Ltd. | 2.62% | ₹ 119.44 | Hospitals & Medical Services |
| Sai Life Sciences Ltd. | 2.54% | ₹ 116 | Pharmaceuticals |
| TREPS | 2.48% | ₹ 113.18 | Others |
| Sudeep Pharma Ltd. | 2.21% | ₹ 100.93 | Pharmaceuticals |
| Lonza Group | 2.14% | ₹ 97.66 | Others |
| Alkem Laboratories Ltd. | 2.11% | ₹ 96.22 | Pharmaceuticals |
| Lupin Ltd. | 1.99% | ₹ 90.71 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 1.99% | ₹ 91.06 | Hospitals & Medical Services |
| Ajanta Pharma Ltd. | 1.92% | ₹ 87.87 | Pharmaceuticals |
| Polymedicure Ltd. | 1.89% | ₹ 86.38 | Medical Equipment & Accessories |
| Cipla Ltd. | 1.84% | ₹ 84.06 | Pharmaceuticals |
| Cohance Lifesciences Ltd. | 1.70% | ₹ 77.67 | Pharmaceuticals |
| Concord Biotech Ltd. | 1.66% | ₹ 75.69 | Pharmaceuticals |
| Abbott India Ltd. | 1.47% | ₹ 67.14 | Pharmaceuticals |
| Global Health Ltd. | 1.46% | ₹ 66.58 | Hospitals & Medical Services |
| Nephrocare Health Service Pvt. Ltd. | 1.05% | ₹ 47.90 | Hospitals & Medical Services |
| Rainbow Children's Medicare Ltd. | 0.91% | ₹ 41.41 | Hospitals & Medical Services |
| Dr. Lal Path labs Ltd. | 0.84% | ₹ 38.58 | Hospitals & Medical Services |
| Gufic Biosciences Ltd. | 0.37% | ₹ 16.69 | Pharmaceuticals |
| 364 DAY T-BILL 19.11.26 | 0.06% | ₹ 2.92 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 9.03% | 13.86% | 16.04% | 25.20% |
| Category returns | 1.67% | 5.74% | 7.21% | 22.82% |
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.24 | 16.07% | 199.31% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.22 | 14.91% | 189.42% | 0.00% | ₹9,724 | 1.75% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹45.05 | 47.68% | 141.02% | 199.16% | ₹16,533 | 0.25% |
Very High
|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹45.05 | 47.68% | 141.02% | 199.16% | ₹16,533 | 0.25% |
Very High
|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹45.12 | 47.68% | 141.02% | 199.16% | ₹16,533 | 0.25% |
Very High
|
|
SBI Gold ETF
ETF
Regular
|
₹125.50 | 47.40% | 140.21% | 195.86% | ₹25,502 | 0.65% |
High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹43.04 | 47.41% | 139.54% | 195.39% | ₹16,533 | 0.41% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹43.05 | 47.39% | 139.51% | 195.36% | ₹16,533 | 0.41% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹43.05 | 47.39% | 139.51% | 195.36% | ₹16,533 | 0.41% |
Very High
|
|
SBI PSU Fund - Direct Plan
Diversified
Direct
|
₹39.45 | 13.06% | 120.58% | 209.67% | ₹6,594 | 0.85% |
Very High
|
|
SBI PSU Fund - Direct Plan
Diversified
Direct
|
₹39.40 | 13.06% | 120.57% | 209.64% | ₹6,594 | 0.85% |
Very High
|
|
SBI PSU Fund - Direct Plan
Diversified
Direct
|
₹39.40 | 13.06% | 120.57% | 209.64% | ₹6,594 | 0.85% |
Very High
|
What is the current NAV of SBI Healthcare Opportunities Fund - Direct Plan IDCW-Reinvestment?
What is the fund size (AUM) of SBI Healthcare Opportunities Fund - Direct Plan IDCW-Reinvestment?
What are the historical returns of SBI Healthcare Opportunities Fund - Direct Plan IDCW-Reinvestment?
What is the risk level of SBI Healthcare Opportunities Fund - Direct Plan IDCW-Reinvestment?
What is the minimum investment amount for SBI Healthcare Opportunities Fund - Direct Plan IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article